Navigation Links
ATIR Classified as "Cell Based" Medicinal Product by the EMEA
Date:12/14/2007

A Classification for Innovative New Treatments

AMSTERDAM, December 14 /PRNewswire/ -- Kiadis Pharma announced today that its lead product ATIR has received approval for regulatory classification as a "cell based" medicinal product by the Innovation Task Force (ITF), a division of the European Medicines Agency (EMEA). Based upon this regulatory classification ATIR is eligible for EMEA procedures. As a next step Kiadis Pharma will file for orphan drug designation with the EMEA to obtain additional product protection upon marketing approval. In November this year ATIR has been granted orphan drug designation by the US Food and Drug Administration (FDA).

ATIR is under development to prevent acute Graft versus Host Disease (GvHD) allowing the use of a mismatched donor for bone marrow transplantations. It's a personalized cell-based treatment prepared according to a proprietary protocol using both a novel small molecule substance and a proprietary medical device. With the official classification of ATIR as a cell based medicinal product by the EMEA, it's now categorized as an Advanced Therapy and considered to be a highly innovative treatment. The benefits are a centralized marketing authorization procedure, which harmonizes and facilitates access to the European market. In addition, it provides access to an expert Committee for Advanced Therapies within the EMEA, to address scientific, legal and regulatory issues during product development.

"We are very pleased having received a cell based medicinal product classification for ATIR. The regulatory guidelines that will rule ATIR are therefore clear and we have subsequently started with the application of the orphan drug designation with the EMEA which will be filed before the end of this year", said Manja Bouman, CEO Kiadis Pharma.

About ATIR

ATIR is designed to prevent life-threatening acute GvHD by eliminating the immune cells from the donor graft that otherwise attack
'/>"/>

SOURCE Kiadis Pharma
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Non-medicinal treatment touted for pre-schoolers with ADHD
2. Nonmedicinal treatment touted for preschoolers with ADHD
3. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
4. Physician Skin Care Specialist Says Proposed New Rules for Sunscreen Products Will Better Protect the Public
5. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
6. Three Batesville Casket Company Production Facilities Honored for Manufacturing Expertise by National Organizations
7. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
8. End-to-End HR Performance Benchmarks: Metrics That Will Help Turn the HR Cost Center into a Productivity Driver
9. Boston Micromachines Multi-DM Named One of the Years Most Innovative Products
10. Drug Detection Kits Manufactured By IDenta Corp. Shown During French Television Broadcast (at TF1) - Product Aids French Police In Bust of 600 Kilograms Of Cocaine
11. Why Are Most Health & Wellness Products Doomed to Failure?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... (PRWEB) June 18, 2013 San ... Award®, distinguishing it as one of the 2013 ... The award is based on robust criteria that ... clinical excellence considerations. WomenCertified awards products and services ... serves to empower women to make smart healthcare ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 The new ... increased fluid retention through the tip allowing for faster ... Salimetrics Infant Swab (SIS) can be tested ... Chromogranin A. , The diameter of the Salimetrics Infant ... the new swab to access more saliva in the ...
(Date:6/17/2013)... Oak Brook, IL (PRWEB) June 17, 2013 ... researchers found that two MRI measurements of the abdominal ... and the thickness of its wall — are associated ... or stroke. Results of the study are published online ... study, because it demonstrates that atherosclerosis in an artery ...
(Date:6/17/2013)... of more than 2,000 adults, researchers found that two ... of plaque in the vessel and the thickness of ... such as a heart attack or stroke. Results of ... Radiology . , "This is an important study, because ... heart is an independent predictor of adverse cardiovascular events," ...
(Date:6/17/2013)... Daimer Industries, Inc.®, a well-renowned U.S. based ... as expertly designed carpet steam cleaner and vapor steam ... for apartment dwellers and homeowners. The commercial steam cleaner ... and pressure levels up to 75 psi to clean ... to clean carpet spots and areas in homes, but ...
Breaking Medicine News(10 mins):Health News:San Antonio Community Hospital Earns the Women’s Choice Award for Excellence in Orthopedics 2Health News:San Antonio Community Hospital Earns the Women’s Choice Award for Excellence in Orthopedics 3Health News:Salimetrics Redesigns Infant Swab for Faster, Easier Collection 2Health News:RSNA: Atherosclerosis in Abdominal Aorta May Signal Future Heart Attack, Stroke 2Health News:RSNA: Atherosclerosis in Abdominal Aorta May Signal Future Heart Attack, Stroke 3Health News:Atherosclerosis in abdominal aorta may signal future heart attack, stroke 2Health News:Daimer Ships Vapor Steam Cleaner For Homeowners 2Health News:Daimer Ships Vapor Steam Cleaner For Homeowners 3
... , WEDNESDAY, May 16 (HealthDay News) -- Two stroke patients who ... to use their brains to move a robotic arm, researchers report. ... to grasp a thermos of water, bring the thermos to her ... the first time she reached out and picked up anything in ...
... WEDNESDAY, May 16 (HealthDay News) -- New drugs are approved ... new research shows. The findings counter a common belief ... Administration is especially slow, according to Yale University School of ... between 2001 and 2010 by the FDA, Health Canada ...
... Reinberg HealthDay Reporter , WEDNESDAY, May 16 ... slightly raise the risk of death in patients with ... have been tied to an increased risk of sudden ... azithromycin (Zithromax) might be part of that group, said ...
... Reporter , WEDNESDAY, May 16 (HealthDay News) -- Many primary ... chemotherapy treatments that cancer survivors under their care may have ... hand, most oncologists -- though not all -- are familiar ... treat breast and colon cancer, according to the results of ...
... By Randy Dotinga HealthDay Reporter , TUESDAY, May ... panel recommended Tuesday approval of the first HIV test that would ... The 17 panel members were unanimous in voting that the ... test kit, known as Oraquick, detects the presence of HIV -- ...
... 16 (HealthDay News) -- A dangerous antibiotic-resistant "superbug" appears ... spreads to smaller hospitals, according to a new study. ... analyzed the genetic makeup of more than 80 variants ... (MRSA) bacteria found in hospitals. Their findings ...
Cached Medicine News:Health News:Paralyzed Patients Use Mind to Move Robotic Arm 2Health News:Paralyzed Patients Use Mind to Move Robotic Arm 3Health News:Study Links Antibiotic to Slight Rise in Heart Patients' Death Risk 2Health News:Many Primary Care Docs Don't Know Long-Term Effects of Chemo: Survey 2Health News:Many Primary Care Docs Don't Know Long-Term Effects of Chemo: Survey 3Health News:FDA Panel Backs At-Home HIV Test 2Health News:FDA Panel Backs At-Home HIV Test 3Health News:Urban Hospitals May Act as Breeding Ground for MRSA 2
(Date:6/17/2013)... The law firm of Rheingold, Valet, Rheingold, McCartney ... be the first suit in New York ... of two common anti-diabetic drugs, Byetta and Janumet (also known ... resident Robert Cataletto , was filed on June ... CV 13-3411. Mr. Cataletto received prescriptions from the ...
(Date:6/17/2013)... , June 17, 2013 /PRNewswire/ ... presents China Pharmaceutical Guidebook: Latest Chinese ... http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/china-pharmaceutical-guidebook-latest-chinese-regulations-for-imported-drug-registration.html ).      (Logo: ... possesses a fourth population ... of the largest drug markets round ...
(Date:6/17/2013)... BIRMINGHAM, Ala. , June 17, 2013   ... J. Tipton , Ph.D., has been selected by its ... of Southern Research effective July 8, 2013.   ... replaces John A. "Jack" Secrist, III, Ph.D., who served ... seven years. Secrist announced his retirement earlier this year ...
Breaking Medicine Technology:Suit filed for Pancreatic Cancer By Use of Byetta, Januvia and Janumet 2China Pharmaceutical Guidebook: Latest Chinese Regulations for Imported Drug Registration 2China Pharmaceutical Guidebook: Latest Chinese Regulations for Imported Drug Registration 3China Pharmaceutical Guidebook: Latest Chinese Regulations for Imported Drug Registration 4Southern Research Institute Names Arthur J. Tipton, Ph.D. President and CEO 2Southern Research Institute Names Arthur J. Tipton, Ph.D. President and CEO 3
... process makes the Optivac® the clear ... Optivac® Vacuum Mixing System is the ... since its original introduction in 1986. ... homogenous cement, with the lowest possible ...
... Bone Cement, a high viscosity antibiotic bone ... for over a decade, eliminates the inconvenience ... premixed powder helps to prevent inconsistency in ... provides the same proven characteristics and setting ...
... For over 35 years, Palacos ... itself as the gold standard ... since the introduction of,the Optivac ... combination has provided thousands of ...
... Laser Doppler Flowmetry System for Two-Dimensional ... Heidelberg Retina Flowmeter uniquely merges two ... and laser Doppler flowmetry, to a ... non-invasive two-dimensional mapping of the retinal ...
Medicine Products: